Is DHR up or down today?
DHR is up 0.94% today, last at 230.11. This stock moved +0.94% versus the prior close.
DHR · Danaher Corporation
DHR (Danaher Corporation) is trading at 230.11, up 0.94% on the session. DHR sits at the 84% mark of its 52-week range, carries a 14-day RSI of 55, and trades above its 50-day average. Over the past month it is up 4.02%.
Leading the coverage: “AI in Pathology Market Size, Share, Trends, and Global Forecast 2026-2036 | A $1.72 Billion Opportunity Featuring Profiles of Key Players Leica Biosystems (Danaher), Roche, Hamamatsu Photonics, Fujifilm, Agilent Technologies” (Yahoo, 5d ago). DHR is -0.60% since story.
DHR trades on a trailing P/E of 37.6 and is running 6.66% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
DHR is up 0.94% today, last at 230.11. This stock moved +0.94% versus the prior close.
Leading the coverage: “AI in Pathology Market Size, Share, Trends, and Global Forecast 2026-2036 | A $1.72 Billion Opportunity Featuring Profiles of Key Players Leica Biosystems (Danaher), Roche, Hamamatsu Photonics, Fujifilm, Agilent Technologies” (Yahoo, 5d ago). DHR is -0.60% since story. Dominant story: Danaher (NYSE:DHR) Sets Up for Breakout With Strong Technical Ratings - ChartMill (2 sources, bullish) RSI is 55 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: May 2026 – Nov 2026 (125 days) · Drag or scroll left for earlier dates
Danaher (NYSE:DHR) Sets Up for Breakout With Strong Technical Ratings - ChartMill
Danaher (NYSE:DHR) Sets Up for Breakout With Strong Technical Ratings
Danaher Corporation (DHR) Stock forecasts - Yahoo Finance UK
Danaher unit Cepheid wins FDA nod for Xpert Hemorrhagic Fever Panel
Bioprocess Automation Software Market Report 2026: Global Trends and Forecast to 2030 | Capitalize on 12.2% CAGR with Honeywell, Danaher, Siemens and Rockwell